Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch

被引:23
作者
Wang, Xin [1 ]
Gou, Xiaoli [2 ]
Yu, Xiaojuan [2 ]
Bai, Dongdong [2 ]
Tan, Bowei [2 ]
Cao, Pingfeng [2 ]
Qian, Meilin [2 ]
Zheng, Xiaoxiao [2 ]
Wang, Hairong [2 ]
Tang, Pingming [2 ]
Zhang, Chen [2 ]
Ye, Fei [2 ]
Ni, Jia [2 ]
机构
[1] Xinjiang Med Univ, Intens Care Unit, Affiliated Hosp 1, Urumqi, Peoples R China
[2] Haisco Pharmaceut Grp Co Ltd, Ctr Drug Res & Dev, Chegdu, Peoples R China
关键词
HSK21542; kappa opioid receptor; pain; pruritus; animal models; CHRONIC CONSTRICTION INJURY; PROTEIN-BIASED LIGAND; QUANTITATIVE ASSESSMENT; SUBSTANTIA-GELATINOSA; SCRATCHING BEHAVIOR; NEUROPATHIC PAIN; RAT MODEL; MU; NALFURAFINE; RESPONSES;
D O I
10.3389/fphar.2021.773204
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Kappa opioid receptor (KOR) agonists have been promising therapeutic candidates, owing to their potential for relieving pain and treating intractable pruritus. Although lacking morphine-like central nervous system (CNS) effects, KOR agonists do elicit sedation, dysphoria and diuresis which seriously impede their development. Peripherally-restricted KOR agonists have a poor ability to penetrate into the CNS system, so that CNS-related adverse effects can be ameliorated or even abolished. However, the only approved peripherally-restricted KOR agonist CR845 remains some frequent CNS adverse events. In the present study, we aim to address pharmacological profiles of HSK21542, with an expectation to provide a safe and effective alternative for patients who are suffering from pain and pruritus. The in vitro experimental results showed that HSK21542 was a selective and potent KOR agonist with higher potency than CR845, and had a brain/plasma concentration ratio of 0.001, indicating its peripheral selectivity. In animal models of pain, HSK21542 significantly inhibited acetic acid-, hindpaw incision- or chronic constriction injury-induced pain-related behaviors, and the efficacy was comparable to CR845 at 15 min post-dosing. HSK21542 had a long-lasting analgesic potency with a median effective dose of 1.48 mg/kg at 24 h post-drug in writhing test. Meanwhile, the antinociceptive activity of HSK21542 was effectively reversed by a KOR antagonist nor-binaltorphimine. In addition, HSK21542 had powerful antipruritic activities in compound 48/80-induced itch model. On the other hand, HSK21542 had a weak ability to produce central antinociceptive effects in a hot-plate test and fewer effects on the locomotor activity of mice. HSK21542 didn't affect the respiratory rate of mice. Therefore, HSK21542 might be a safe and effective KOR agonist and promising candidate for treating pain and pruritus.
引用
收藏
页数:13
相关论文
共 56 条
[21]   Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity [J].
Gupta, Achla ;
Gomes, Ivone ;
Bobeck, Erin N. ;
Fakira, Amanda K. ;
Massaro, Nicholas P. ;
Sharma, Indrajeet ;
Cave, Adrien ;
Hamm, Heidi E. ;
Parello, Joseph ;
Devi, Lakshmi A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (21) :6041-6046
[22]   Responsiveness of C Neurons in Rat Dorsal Root Ganglion to 5-Hydroxytryptamine-Induced Pruritic Stimuli In Vivo [J].
Hachisuka, Junichi ;
Furue, Hidemasa ;
Furue, Masutaka ;
Yoshimura, Megumu .
JOURNAL OF NEUROPHYSIOLOGY, 2010, 104 (01) :271-279
[23]   Oxycodone-induced tolerance to respiratory depression: reversal by ethanol, pregabalin and protein kinase C inhibition [J].
Hill, Rob ;
Dewey, William L. ;
Kelly, Eamonn ;
Henderson, Graeme .
BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (12) :2492-2503
[24]   The novel μ-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception [J].
Hill, Rob ;
Disney, Alex ;
Conibear, Alex ;
Sutcliffe, Katy ;
Dewey, William ;
Husbands, Stephen ;
Bailey, Chris ;
Kelly, Eamonn ;
Henderson, Graeme .
BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (13) :2653-2661
[25]   NALFURAFINE PREVENTS 5′-GUANIDINONALTRINDOLE- AND COMPOUND 48/80-INDUCED SPINAL c-fos EXPRESSION AND ATTENUATES 5′-GUANIDINONALTRINDOLE-ELICITED SCRATCHING BEHAVIOR IN MICE [J].
Inan, S. ;
Dun, N. J. ;
Cowan, A. .
NEUROSCIENCE, 2009, 163 (01) :23-33
[26]   Nalfurafine hydrochloride to treat pruritus: a review [J].
Inui, Shigeki .
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2015, 8 :249-255
[27]   Dynorphin Acts as a Neuromodulator to Inhibit Itch in the Dorsal Horn of the Spinal Cord [J].
Kardon, Adam P. ;
Polgar, Erika ;
Hachisuka, Junichi ;
Snyder, Lindsey M. ;
Cameron, Darren ;
Savage, Sinead ;
Cai, Xiaoyun ;
Karnup, Sergei ;
Fan, Christopher R. ;
Hemenway, Gregory M. ;
Bernard, Carcha S. ;
Schwartz, Erica S. ;
Nagase, Hiroshi ;
Schwarzer, Christoph ;
Watanabe, Masahiko ;
Furuta, Takahiro ;
Kaneko, Takeshi ;
Koerber, H. Richard ;
Todd, Andrew J. ;
Ross, Sarah E. .
NEURON, 2014, 82 (03) :573-586
[28]   Exploring the opioid system by gene knockout [J].
Kieffer, BL ;
Gavériaux-Ruff, C .
PROGRESS IN NEUROBIOLOGY, 2002, 66 (05) :285-306
[29]   Dietary intake of the flower extracts of German Chamomile (Matricaria recutita L.) inhibited compound 48/80-induced itch-scratch responses in mice [J].
Kobayashi, Y ;
Nakano, Y ;
Inayama, K ;
Sakai, A ;
Kamiya, T .
PHYTOMEDICINE, 2003, 10 (08) :657-664
[30]   Dynorphin A activates bradykinin receptors to maintain neuropathic pain [J].
Lai, Josephine ;
Luo, Miaw-Chyi ;
Chen, Qingmin ;
Ma, Shouwu ;
Gardell, Luis R. ;
Ossipov, Michael H. ;
Porreca, Frank .
NATURE NEUROSCIENCE, 2006, 9 (12) :1534-1540